再生療法の世界市場：組織タイプ別、アプリケーション別、エンドユーザー別、地域別－規模、シェア、展望、機会分析（2022年～2028年）

組織工学や生体医工学に関する標準化ガイドラインの欠如が、世界の再生療法市場の成長を阻害すると予想されます。また、臨床試験に時間がかかるため、市場への製品投入が遅れることも、市場の成長を抑制する要因になると考えられます。

当レポートでは、世界の再生療法市場について調査しており、市場展望、市場力学、市場分析、競合情勢など、包括的な情報を提供しています。

目次

第1章 調査目的・前提条件

• 調査目的
• 仮定
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
  • 市場の内訳：組織タイプ別
  • 市場の内訳：アプリケーション別
  • 市場の内訳：エンドユーザー別
• コヒーレントオポチュニティマップ（COM）

第3章 市場力学、規制、および動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 市場機会
• 影響分析
• 主な開発
• 規制シナリオ
• PEST分析

第4章 世界の再生療法市場：組織タイプ別（100万米ドル）（2017年～2028年）

• イントロダクション
• 同種移植
• 異種移植
• 無生物材料移植

第5章 世界の再生療法市場：アプリケーション別（100万米ドル）（2017年～2028年）

• イントロダクション
• 軟組織の修復
• 心血管
• 歯科
• 整形外科
• 中枢神経系疾患の治療
• その他

第6章 世界の再生療法市場：エンドユーザー別（100万米ドル）（2017年～2028年）

• イントロダクション
• 病院
• 外来手術センター
• 教育機関

第7章 世界の再生療法市場：地域別（100万米ドル）（2017年～2028年）

• イントロダクション
• 北米
• 米国
• カナダ
• 欧州
• 英国
• ドイツ
• イタリア
• フランス
• スペイン
• ロシア
• その他の欧州
• アジア太平洋
• 中国
• インド
• 日本
• ASEAN諸国
• オーストラリア
• 韓国
• その他のアジア太平洋
• ラテンアメリカ
• ブラジル
• メキシコ
• アルゼンチン
• その他のラテンアメリカ
• 中東
• GCC諸国
• イスラエル
• その他の中東
• アフリカ
• 北アフリカ
• 中央アフリカ
• 南アフリカ

第8章 競合情勢

• 企業プロファイル
• Shire Pharmaceuticals
• Kinetic Concepts, Inc.
• Mesoblast Ltd.
• Nuo Therapeutics(Cytomedix Inc.)
• Advanced Cell Technology, Inc.
• BioStem Life Sciences
• Akron Biotechnology, LLC
• Organovo Holdings Inc.
• Orgenesis Inc.
• Pluristem Therapeutics Inc.
• Genzyme
• Athersys, Inc.
• RenovaCare, Inc.
• Cytori Therapeutics, Inc.

第9章 セクション

• 参考文献
• 調査手法
• 当社と営業窓口について

Regenerative medicine is one the fastest emerging fields of medicine, as it adopts stem cells for treatment. Increasing age or injury, makes it difficult to provide the optimum amount of stem cells that are needed to maintain the normal function. The goal of regenerative medicine is to amplify this natural repair system to keep pace with the demands of the patients. Orthopedics is one of the fields of regenerative medicine, which adopts natural healing process by stimulating regeneration of cells in the musculoskeletal system. Histogen Inc. is one of the manufacturer of orthopedic regenerative medicine and its product Human Extracellular matrix (hECM) is anti-inflammatory, angiogenic, and can stimulate growth of stem cells in damaged areas to induce tissue regeneration.

Restraints of the Global Regenerative Therapies Market

Lack of standardized guidelines on tissue and bio-medical engineering is expected to hinder growth of the global regenerative therapies market. Moreover, lengthy clinical trials leading to delayed entry of products in the market is expected to restrain growth of the market.

Key features of the study:

This report provides in-depth analysis of the global regenerative therapies market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players

It profiles leading players in the global regenerative therapies market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans

Key companies covered as a part of this study include Shire Pharmaceuticals, Kinetic Concepts, Inc., Mesoblast Ltd., Nuo Therapeutics (Cytomedix Inc.), Advanced Cell Technology, Inc., BioStem Life Sciences, Akron Biotechnology, LLC, Organovo Holdings Inc., Orgenesis Inc., Pluristem Therapeutics Inc., Genzyme, Athersys, Inc., RenovaCare, Inc., and Cytori Therapeutics, Inc.

Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics

The global regenerative therapies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

Global Regenerative Therapies Market, By Tissue Type:

Allograft

Xenograft

Alloplast

Global Regenerative Therapies Market, By Application:

Soft Tissue Repair

Cardiovascular

Dental

Orthopedic

CNS disease treatment

Others

Global Regenerative Therapies Market, By End User:

Hospitals

Ambulatory Surgical Centers

Educational Institutes

Global Regenerative Therapies Market, By Geography:

North America

By Tissue Type

Allograft

Xenograft

Alloplast

By Application

Soft Tissue Repair

Cardiovascular

Dental

Orthopedic

CNS disease treatment

Others

By End User

Hospitals

Ambulatory Surgical Centers

Educational Institutes

By Country:

U.S.

Canada

Europe

By Tissue Type

Allograft

Xenograft

Alloplast

By Application

Soft Tissue Repair

Cardiovascular

Dental

Orthopedic

CNS disease treatment

Others

By End User

Hospitals

Ambulatory Surgical Centers

Educational Institutes

By Country:

U.K.

Germany

Italy

France

Spain

Russia

Rest of Europe

Asia Pacific

By Tissue Type

Allograft

Xenograft

Alloplast

By Application

Soft Tissue Repair

Cardiovascular

Dental

Orthopedic

CNS disease treatment

Others

By End User

Hospitals

Ambulatory Surgical Centers

Educational Institutes

By Country:

China

India

Japan

ASEAN

Australia

South Korea

Rest of Asia Pacific

Latin America

By Tissue Type

Allograft

Xenograft

Alloplast

By Application

Soft Tissue Repair

Cardiovascular

Dental

Orthopedic

CNS disease treatment

Others

By End User

Hospitals

Ambulatory Surgical Centers

Educational Institutes

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

Middle East:

By Tissue Type

Allograft

Xenograft

Alloplast

By Application

Soft Tissue Repair

Cardiovascular

Dental

Orthopedic

CNS disease treatment

Others

By End User

Hospitals

Ambulatory Surgical Centers

Educational Institutes

By Country:

GCC

Israel

Rest of Middle East

Africa

By Tissue Type

Allograft

Xenograft

Alloplast

By Application

Soft Tissue Repair

Cardiovascular

Dental

Orthopedic

CNS disease treatment

Others

By End User

Hospitals

Ambulatory Surgical Centers

Educational Institutes

By Country/Region:

Central Africa

South Africa

North Africa

Company Profiles

Shire Pharmaceuticals *

Company Overview

Product Portfolio

Financial Performance

Key Strategies

Recent Developments

Kinetic Concepts, Inc.

Mesoblast Ltd.

Nuo Therapeutics (Cytomedix Inc.)

Advanced Cell Technology, Inc.

BioStem Life Sciences

Akron Biotechnology, LLC

Organovo Holdings Inc.

Orgenesis Inc.

Pluristem Therapeutics Inc.

Genzyme

Athersys, Inc.

RenovaCare, Inc.

Cytori Therapeutics, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
• Market Definition and Scope
  • Executive Summary
• Market Snippet, By Tissue Type
• Market Snippet, By Application
• Market Snippet, By End User
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• Market Opportunities
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • PEST Analysis

4. Global Regenerative Therapies Market, By Tissue Type, 2017 - 2028 (US$ Mn)

• Introduction
• Market Share Analysis, 2022 and 2028 (%)
• Y-o-Y Growth Analysis, 2017 - 2028
• Segment Trends
  • Allograft
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Segment Trends
  • Xenograft
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Segment Trends
  • Alloplast
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Segment Trends

5. Global Regenerative Therapies Market, By Application, 2017 - 2028 (US$ Mn)

• Introduction
• Market Share Analysis, 2022 and 2028 (%)
• Y-o-Y Growth Analysis, 2017 - 2028
• Segment Trends
  • Soft Tissue Repair
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Cardiovascular
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Dental
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Orthopedic
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • CNS disease treatment
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Others
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Regenerative Therapies Market, By End User, 2017 - 2028 (US$ Mn)

• Introduction
• Market Share Analysis, 2022 and 2028 (%)
• Y-o-Y Growth Analysis, 2017 - 2028
• Segment Trends
  • Hospitals
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Ambulatory Surgical Centers
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Educational Institutes
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Regenerative Therapies Market, By Regions, 2017 - 2028 (US$ Mn)

• Introduction
• Market Share Analysis, 2022 and 2028 (%)
• Y-o-Y Growth Analysis, 2017 - 2028
• Segment Trends
  • North America
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • U.S.
  • Canada
  • Europe
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

8. Competitive Landscape

• Company Profiles
• Shire Pharmaceuticals
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Kinetic Concepts, Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Mesoblast Ltd.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Nuo Therapeutics (Cytomedix Inc.)
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Advanced Cell Technology, Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• BioStem Life Sciences
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Akron Biotechnology, LLC
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Organovo Holdings Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Orgenesis Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pluristem Therapeutics Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Genzyme
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Athersys, Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• RenovaCare, Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cytori Therapeutics, Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

9. Section

• References
• Research Methodology
• About us and Sales Contact